A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community Population

NCT04786704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12106

Last updated 2022-06-28

No results posted yet for this study

Summary

to determine screening value of stool-based SDC2 DNA methylation test for advanced colorectal neoplasia in the asymptomatic Chinese community population.

Conditions

Interventions

DIAGNOSTIC_TEST

Stool-based SDC2 DNA methylation test

A diagnostic device measuring syndecan 2(SDC2) methylation status in stool DNA to detect colorectal cancer

DIAGNOSTIC_TEST

quantitative Fecal immunochemical test

A diagnostic device using immunoturbidimetric methods to measure fecal hemoglobin concentration

Sponsors & Collaborators

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Gongli Hospital of Shanghai Pudong New Area

    collaborator UNKNOWN
  • Shanghai Songjiang District Central Hospital

    collaborator UNKNOWN
  • Shanghai Jing'an District Central Hospital

    collaborator UNKNOWN
  • Tongji University

    collaborator OTHER
  • Qingyuan People's Hospital

    collaborator OTHER
  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • 900 Hospital of Joint Logistics Support Force of PLA

    collaborator OTHER
  • First Affiliated Hospital of Suzhou Medical College

    collaborator OTHER
  • Affiliated Hospital of Jiangnan University

    collaborator OTHER
  • Traditional Chinese Medicine Hosipital of Kunshan

    collaborator UNKNOWN
  • Ankang Central Hospital

    collaborator OTHER
  • Shandong Cancer Hospital and Institute

    collaborator OTHER
  • Ningjin County Hospital

    collaborator UNKNOWN
  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Zhaoshen Li, MD · Changhai Hospital, Navy/Second Military Medical University

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-22
Primary Completion
2022-06-15
Completion
2022-06-25

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04786704 on ClinicalTrials.gov